Caridad Galindo-Romero

Dr. Caridad Galindo-Romero

Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Experimental Eye Research
Verified
Journal Article
Closed access
CGCaridad Galindo-Romero
Caridad Galindo-Romero
MAMarcelino Avilés-Trigueros
Marcelino Avilés-Trigueros
MJM. Jiménez-López
M. Jiménez-López
Francisco Javier Valiente-SorianoFrancisco Javier Valiente-Soriano
Francisco Javier Valiente-Soriano
MSM. Salinas-Navarro
M. Salinas-Navarro
MAMarta Agudo-Barriuso
Marta Agudo-Barriuso

1 February 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
CGCaridad Galindo-Romero
Caridad Galindo-Romero
FVF. Javier Valiente-Soriano
F. Javier Valiente-Soriano
MJM. Jiménez-López
M. Jiménez-López
Diego García-AyusoDiego García-Ayuso
Diego García-Ayuso
MVMaria P. Villegas-Pérez
Maria P. Villegas-Pérez
MAMarta Agudo-Barriuso
Marta Agudo-Barriuso
Purpose. To assess the effect of a single intravitreal injection of brain-derived neurotrophic factor (BDNF) on the survival of mouse retinal ganglion cells (RGCs) and on phagocytic microglia after intraorbital optic nerve transection (IONT). Methods. One week before IONT or processing, RGCs from pigmented C57/BL6 and albino Swiss mice were traced by applying hydroxystilbamidine methanesulfonate (OHSt) to both superior colliculi. Right afterward unilateral IONT, BDNF or vehicle were intravitreally administered. At increasing time intervals postlesion retinas were dissected as flat-mounts and subjected to BRN3A and Iba1 immunodetection. BRN3A+RGCs were automatically quantified in all retinas and their distribution was assessed using isodensity maps. In all retinas, the Iba1-positive and OHSt-filled microglial cells present in the ganglion cell layer were manually quantified. Their distribution was observed by neighbor maps. Results. When vehicle was administered, IONT-induced RGC death was significant at 3 days, while BDNF treatment delayed it to 5 days. At 14 days after BDNF or vehicle injection, 45% and 18% of RGCs had survived, respectively. There was a significant increase in OHSt-filled microglial cells in the right (contralateral) retinas after both treatments, without concurring with quantifiable RGC death. In the injured eye, the number of OHSt-filled microglial cells increased as the population of RGCs decreased and spread from central to peripheral areas. Conclusions. In axotomized mouse retinas, a single intravitreal injection of BDNF protects RGCs throughout the whole retina. There is a strong contralateral response that involves microglial activation and OHSt phagocytosis.

26 April 2017 in Frontiers in Neuroscience
Verified
Journal Article
Open access
Manuel Vidal-SanzManuel Vidal-Sanz
Manuel Vidal-Sanz
CGCaridad Galindo-Romero
Caridad Galindo-Romero
Francisco Javier Valiente-SorianoFrancisco Javier Valiente-Soriano
Francisco Javier Valiente-Soriano
FNFrancisco M Nadal-Nicolas
Francisco M Nadal-Nicolas
AMArturo Ortin Martinez
Arturo Ortin Martinez
MAMarta Agudo-Barriuso
Marta Agudo-Barriuso
Glaucoma, one of the leading causes of blindness worldwide, affects primarily retinal ganglion cells (RGCs) and their axons. The pathophysiology of gl aucoma is not fully understood, but it is currently believed that damage to RGC axons at the optic nerve head plays a major role. Rodent models to study glaucoma include those that mimic either ocular hypertension or optic nerve injury. Here we review the anatomical loss of the general population of RGCs (that express Brn3a; Brn3a+RGCs) and of the intrinsically photosensitive RGCs (that express melanopsin; m+RGCs) after chronic (LP-OHT) or acute (A-OHT) ocular hypertension and after complete intraorbital optic nerve transection (ONT) or crush (ONC). Our studies show that all of these insults trigger RGC death. Compared to Brn3a+RGCs, m+RGCs are more resilient to ONT, ONC and A-OHT but not to LP-OHT. There are differences in the course of RGC loss both between these RGC types and among injuries. An important difference between the damage caused by ocular hypertension or opti nerve injury appears in the outer retina. Both axotomy and LP-OHT induce selective loss of RGCs but LP-OHT also induces a protracted loss of cone photoreceptors. This review outlines our current understanding of the anatomical changes occurring in rodent models of glaucoma and discusses the advantages of each one and their translational value.

1 December 2019 in Journal of Controlled Release
Verified
Journal Article
Open access
RBRaquel Boia
Raquel Boia
PDPaulo Alexandre Neves Dias
Paulo Alexandre Neves Dias
JMJoana M. Martins
Joana M. Martins
CGCaridad Galindo-Romero
Caridad Galindo-Romero
IAInês Dinis Aires
Inês Dinis Aires
ASAna Raquel Santiago
Ana Raquel Santiago
This work reports the development of porous poly (ε-caprolactone) (PCL)-based intraocular implants, prepared by green supercritical carbon dioxide (scCO2) foaming/mixing method (SFM), to produce implants that degrade faster than typical slow-degrading PCL-based implants. The higher porosities and surface areas of these implants led to faster degradation rates at in vitro accelerated alkaline conditions than low porosity/surface area implants prepared by hot melting processing. These porous implants also presented distinct (faster) release rates of a test-drug (dexamethasone). Additionally, these porous devices did not cause cell death and did not reduce the number of neurons, indicating that are not toxic to retinal cells. We further explored the impact of PCL-based implant to the retina by in vivo evaluation and histological analysis. Implants were surgically inserted in the vitreous of Wistar rats, and their presence did not change the function, structure and anatomy of the retina. These devices demonstrated a good intraocular tolerance, further confirming their viability for prolonged drug delivery applications. Further comprehensive studies based on this promising preliminary assessment and proof-of-concept could enable its future translation to clinical protective strategies for retinal diseases.

12 October 2010 in Vision Research
Verified
Journal Article
Closed access
LALuis Alarcón-Martínez
Luis Alarcón-Martínez
MAMarcelino Avilés-Trigueros
Marcelino Avilés-Trigueros
CGCaridad Galindo-Romero
Caridad Galindo-Romero
JVJavier Valiente-Soriano
Javier Valiente-Soriano
MAMarta Agudo-Barriuso
Marta Agudo-Barriuso
MVManuel Vidal-Sanz
Manuel Vidal-Sanz

1 March 2013 in Experimental Eye Research
Verified
Journal Article
Closed access
CGCaridad Galindo-Romero
Caridad Galindo-Romero
MJM. Jiménez-López
M. Jiménez-López
Diego García-AyusoDiego García-Ayuso
Diego García-Ayuso
MSM. Salinas-Navarro
M. Salinas-Navarro
FNFrancisco M Nadal-Nicolas
Francisco M Nadal-Nicolas
MVM. Vidal-Sanz
M. Vidal-Sanz